MX9706275A - El uso del alendronato para preparar composiciones para reducir el riesgo de fracturas vertebrales. - Google Patents
El uso del alendronato para preparar composiciones para reducir el riesgo de fracturas vertebrales.Info
- Publication number
- MX9706275A MX9706275A MX9706275A MX9706275A MX9706275A MX 9706275 A MX9706275 A MX 9706275A MX 9706275 A MX9706275 A MX 9706275A MX 9706275 A MX9706275 A MX 9706275A MX 9706275 A MX9706275 A MX 9706275A
- Authority
- MX
- Mexico
- Prior art keywords
- lessening
- risk
- vertebral fractures
- fractures
- alendronate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
El alendronato, un bisfosfonato, cuando se administra diariamente durante un periodo substancial, puede reducir la tasa de fracturas vertebrales en mujeres post-menopausicas; además, puede reducir el numero y la severidad de las fracturas; asimismo, la administracion del alendronato puede prevenir la deformidad de la espina dorsal, y la pérdida de peso.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/389,860 US20010051616A1 (en) | 1995-02-17 | 1995-02-17 | Method of lessening the risk of vertebral fractures |
US08389860 | 1995-02-17 | ||
PCT/US1996/001946 WO1996025166A1 (en) | 1995-02-17 | 1996-02-13 | Method of lessening the risk of vertebral fractures |
Publications (2)
Publication Number | Publication Date |
---|---|
MX9706275A true MX9706275A (es) | 1997-11-29 |
MXPA97006275A MXPA97006275A (es) | 1998-07-03 |
Family
ID=
Also Published As
Publication number | Publication date |
---|---|
HUP9802077A2 (hu) | 2000-06-28 |
EP0809503A4 (en) | 2001-12-05 |
CN1181008A (zh) | 1998-05-06 |
AU689379B2 (en) | 1998-03-26 |
WO1996025166A1 (en) | 1996-08-22 |
EP0809503A1 (en) | 1997-12-03 |
KR19980702209A (ko) | 1998-07-15 |
JPH11501906A (ja) | 1999-02-16 |
HUP9802077A3 (en) | 2001-10-29 |
SK111697A3 (en) | 1998-02-04 |
EA199700185A1 (ru) | 1997-12-30 |
NZ303476A (en) | 2000-07-28 |
US20010051616A1 (en) | 2001-12-13 |
EA000348B1 (ru) | 1999-04-29 |
CA2213076A1 (en) | 1996-08-22 |
ZA961234B (en) | 1996-08-27 |
PL321836A1 (en) | 1997-12-22 |
AU4979996A (en) | 1996-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH30032A (en) | Methods for inhibiting bone loss | |
ZA964816B (en) | Implant for the surgical treatment of a vertebral isthmus fracture. | |
MY114265A (en) | Alendronate therapy to prevent loosening of, or pain associated with orthopedic implant devices | |
AU1432795A (en) | Devices and methods for posterior spinal fixation | |
MX9207349A (es) | Metodos para el tratamiento de osteoporosis utilizando bisfosfonatos y hormona de paratiroides. | |
CA2262269A1 (en) | Treatment of skeletal disorders | |
GB2228417B (en) | Posterior spinal system and method | |
IL134564A0 (en) | A pharmaceutical composition for treating dysmenorrhea and premature labor | |
MX9707535A (es) | Uso de derivados de vitamina d2 o de vitamina d4 en la preparacion de un farmaco para el tratamiento de hiperparatiroidismo secundario. | |
AU5482696A (en) | Orthotic apparatus useful for treating pain associated with spinal disorders | |
ZA944347B (en) | The use of cetrorelix and other nona- and decapeptides in the preparation of a medicament for combating aids and for growth stimulation | |
EP0668750A4 (en) | PEDICULAR SCREW AND INSTRUMENTS FOR REAR SPINE CORRECTION. | |
EP0590745A3 (en) | Spinal support system and method. | |
EP0748634A3 (de) | Implantat, seine Verwendung in der Chirurgie und Verfahren zu seiner Herstellung | |
EP0746255A4 (en) | CROSS-LINK FOR VERTEBRAL IMPLANT SYSTEM | |
PL309693A1 (en) | Combined osteoporosis inhibiting treatment | |
GB9408775D0 (en) | Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration | |
NZ303022A (en) | Treatment of osteoporotic diseases with alendronate | |
WO1999004772A3 (en) | Use of levobupivacaine | |
KR100213963B1 (en) | Use of 2,3-diaryl-1-benzopyran derivatives for the manufacture of a medicament in the treatment and prevention of bone loss and osteoporosis | |
HUT68171A (en) | Preparations containing 4-aminopyridine for the treatment of neurological conditions | |
EA199700185A1 (ru) | Способ уменьшения риска вертебральных переломов | |
MX9703944A (es) | Metodo para usar derivados de triaril-etileno en el tratamiento y prevencion de osteoporosis. | |
EP0744176A3 (en) | Methods for inhibiting bone loss | |
AU3607293A (en) | Implant therapy for bone growth stimulation |